Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Maya, Khalil"'
Autor:
Jeffrey M. Conroy, Sarabjot Pabla, Mary K. Nesline, Sean T. Glenn, Antonios Papanicolau-Sengos, Blake Burgher, Jonathan Andreas, Vincent Giamo, Yirong Wang, Felicia L. Lenzo, Wiam Bshara, Maya Khalil, Grace K. Dy, Katherine G. Madden, Keisuke Shirai, Konstantin Dragnev, Laura J. Tafe, Jason Zhu, Matthew Labriola, Daniele Marin, Shannon J. McCall, Jeffrey Clarke, Daniel J. George, Tian Zhang, Matthew Zibelman, Pooja Ghatalia, Isabel Araujo-Fernandez, Luis de la Cruz-Merino, Arun Singavi, Ben George, Alexander C. MacKinnon, Jonathan Thompson, Rajbir Singh, Robin Jacob, Deepa Kasuganti, Neel Shah, Roger Day, Lorenzo Galluzzi, Mark Gardner, Carl Morrison
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)
Abstract Background PD-L1 immunohistochemistry (IHC) has been traditionally used for predicting clinical responses to immune checkpoint inhibitors (ICIs). However, there are at least 4 different assays and antibodies used for PD-L1 IHC, each develope
Externí odkaz:
https://doaj.org/article/ba0a2468e04d487e8d2b8fe0e2e078e6
Autor:
Sapna P. Patel, Megan Othus, Yuanbin Chen, G. Paul Wright, Kathleen J. Yost, John R. Hyngstrom, Siwen Hu-Lieskovan, Christopher D. Lao, Leslie A. Fecher, Thach-Giao Truong, Jennifer L. Eisenstein, Sunandana Chandra, Jeffrey A. Sosman, Kari L. Kendra, Richard C. Wu, Craig E. Devoe, Gary B. Deutsch, Aparna Hegde, Maya Khalil, Ankit Mangla, Amy M. Reese, Merrick I. Ross, Andrew S. Poklepovic, Giao Q. Phan, Adedayo A. Onitilo, Demet G. Yasar, Benjamin C. Powers, Gary C. Doolittle, Gino K. In, Niels Kokot, Geoffrey T. Gibney, Michael B. Atkins, Montaser Shaheen, James A. Warneke, Alexandra Ikeguchi, Jose E. Najera, Bartosz Chmielowski, Joseph G. Crompton, Justin D. Floyd, Eddy Hsueh, Kim A. Margolin, Warren A. Chow, Kenneth F. Grossmann, Eliana Dietrich, Victor G. Prieto, Michael C. Lowe, Elizabeth I. Buchbinder, John M. Kirkwood, Larissa Korde, James Moon, Elad Sharon, Vernon K. Sondak, Antoni Ribas
Publikováno v:
New England Journal of Medicine. 388:813-823
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::572c5454e442063325a108f2b1da3b9a
https://doi.org/10.1056/nejmoa2211437
https://doi.org/10.1056/nejmoa2211437
Publikováno v:
JAMA Oncol
IMPORTANCE: Few clinical trials have been specifically designed for elderly patients with advanced non–small cell lung cancer (NSCLC), and the anticipated increase in the number of such patients has prompted a search for new treatment options that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::662f1ba16b2232e23d2618ffe3ad35a9
https://doi.org/10.21037/tlcr-2020-15
https://doi.org/10.21037/tlcr-2020-15
Autor:
Apar Kishor P, Ganti, Billy W, Loo, Michael, Bassetti, Collin, Blakely, Anne, Chiang, Thomas A, D'Amico, Christopher, D'Avella, Afshin, Dowlati, Robert J, Downey, Martin, Edelman, Charles, Florsheim, Kathryn A, Gold, Jonathan W, Goldman, John C, Grecula, Christine, Hann, Wade, Iams, Puneeth, Iyengar, Karen, Kelly, Maya, Khalil, Marianna, Koczywas, Robert E, Merritt, Nisha, Mohindra, Julian, Molina, Cesar, Moran, Saraswati, Pokharel, Sonam, Puri, Angel, Qin, Chad, Rusthoven, Jacob, Sands, Rafael, Santana-Davila, Michael, Shafique, Saiama N, Waqar, Kristina M, Gregory, Miranda, Hughes
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN, vol 19, iss 12
J Natl Compr Canc Netw
J Natl Compr Canc Netw
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Small Cell Lung Cancer (SCLC) provide recommended management for patients with SCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0afc3127c8fc6539db3773fa2f3106f9
https://escholarship.org/uc/item/5hz141t0
https://escholarship.org/uc/item/5hz141t0
Publikováno v:
Stiehm's Immune Deficiencies ISBN: 9780128167687
It is recognized that certain primary immune deficiencies are associated with increased risk of specific pathogens and this has led to a greater understanding of the role of individual genes in mediating host defense against these pathogens. In a sim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f42c5562ef64d2a39efb927b4b104f3
https://doi.org/10.1016/b978-0-12-816768-7.00051-x
https://doi.org/10.1016/b978-0-12-816768-7.00051-x
Autor:
Michael S. Abers, Daria V. Babushok, Mark Ballow, Bertrand Boisson, Vincent Robert Bonagura, Francisco A. Bonilla, João Bosco de Oliveira Filho, Kaan Boztug, Lori Broderick, Manish J. Butte, Fabio Candotti, Jean-Laurent Casanova, Shanmuganathan Chandrakasan, Antonio Condino-Neto, Yanick J. Crow, Charlotte Cunningham-Rundles, Virgil A.S.H. Dalm, Adriana A. de Jesus, Emma de Maio, Geneviève de Saint Basile, Esther de Vries, Inderjeet Dokal, Christopher J.A. Duncan, A. Durandy, Stephan Ehl, Amos Etzioni, Polly J. Ferguson, Thomas A. Fleisher, Lisa R. Forbes-Satter, Michael M. Frank, Alexandra F. Freeman, Marie-Louise Frémond, John W. Frew, Mathieu Fusaro, Eleonora Gambineri, Rebecca D. Ganetzky, Andrew R. Gennery, Raphaela Goldbach-Mansky, Amy C. Goldstein, John M. Graham, Stephanie E. Gupton, Elie Haddad, Sophie Hambleton, Eric P. Hanson, Jennifer Heimall, Miep Helfrich, Sarah E. Henrickson, Steven M. Holland, Amy P. Hsu, Soma Jyonouchi, Sara Kashef, Judith Kelsen, Maya Khalil, Christoph Klein, Lisa Kobrynski, Donald B. Kohn, S. Kracker, James G. Krueger, Pascal M. Lavoie, Heather K. Lehman, Jennifer W. Leiding, Michael J. Lenardo, Ofer Levy, Allison Pecha Lim, Michail S. Lionakis, Andrea Lisco, Vassilios Lougaris, Saul O. Lugo Reyes, M. Louise Markert, Rebecca A. Marsh, Elizabeth A. McCarthy, Isabelle Meyts, Cinzia Milito, Joshua D. Milner, Jeffrey E. Ming, Despina Moshous, Ludmila Müller, Kristina Navrazhina, Kim E. Nichols, Luigi D. Notarangelo, Eric Oksenhendler, Jordan S. Orange, Roberto Paganelli, Graham Pawelec, Tancredi Massimo Pentimalli, Elena E. Perez, Capucine Picard, Alessandro Plebani, Oscar Porras, Amanda C. Przespolewski, Anne Puel, Federica Pulvirenti, Isabella Quinti, Nima Rezaei, Ger T. Rijkers, David Walter Rosenthal, Sergio D. Rosenzweig, Brahm H. Segal, Mikko R.J. Seppänen, Irini Sereti, Anna Shcherbina, Cristina Sobacchi, Jacqueline D. Squire, Polina Stepensky, Helen C. Su, Kathleen E. Sullivan, Troy R. Torgerson, Gulbu Uzel, Mirjam van der Burg, Anna Villa, Jean-Pierre de Villartay, Klaus Warnatz, Richard L. Wasserman, Corry M.R. Weemaes, Joyce E. Yu, Shen-Ying Zhang, John B. Ziegler
Publikováno v:
Stiehm's Immune Deficiencies ISBN: 9780128167687
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f915fe7ee94350b361b45ad0c2b83b0
https://doi.org/10.1016/b978-0-12-816768-7.01002-4
https://doi.org/10.1016/b978-0-12-816768-7.01002-4
Autor:
Aparna Hegde, Maya Khalil
Publikováno v:
Precision Cancer Medicine. 4:20-20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6020d76c83cec310b2172f2688721910
https://doi.org/10.21037/pcm-21-5
https://doi.org/10.21037/pcm-21-5
Publikováno v:
Lebanese Medical Journal. 64:200-204
Background Proper approach to symptom control in cancer patients requires a good understanding of the prevalence of the various symptoms these patients have. Aim This study aims at assessing the Lebanese oncologists’ point of view concerning the sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::085c3ff016d6d82fd2b3bc22577c4e33
https://doi.org/10.12816/0033790
https://doi.org/10.12816/0033790
Autor:
Lorenzo Galluzzi, Sean T. Glenn, Vincent Giamo, Alexander C. Mackinnon, Jeffrey M. Conroy, Sarabjot Pabla, Jeffrey M. Clarke, Matthew Labriola, Maya Khalil, Isabel Araujo-Fernandez, Carl Morrison, Jonathan Andreas, Rajbir Singh, Blake Burgher, Roger Day, Daniel J. George, Yirong Wang, Laura J. Tafe, Katherine G. Madden, Jason Zhu, Keisuke Shirai, Konstantin H. Dragnev, Mary Nesline, Neel Shah, Robin Jacob, Matthew Zibelman, Felicia L. Lenzo, Shannon J. McCall, Luis de la Cruz-Merino, Arun K Singavi, Antonios Papanicolau-Sengos, Daniele Marin, Pooja Ghatalia, Grace K. Dy, Ben George, Deepa Kasuganti, Wiam Bshara, Tian Zhang, Mark Gardner, Jonathan Thompson
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)
Digital.CSIC. Repositorio Institucional del CSIC
instname
[Background] PD-L1 immunohistochemistry (IHC) has been traditionally used for predicting clinical responses to immune checkpoint inhibitors (ICIs). However, there are at least 4 different assays and antibodies used for PD-L1 IHC, each developed with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04f5bdce7b6bf0c408faca117a7db272
http://hdl.handle.net/10261/213880
http://hdl.handle.net/10261/213880
Publikováno v:
International Journal of Breast Cancer
International Journal of Breast Cancer, Vol 2018 (2018)
International Journal of Breast Cancer, Vol 2018 (2018)
Introduction. Accurate evaluation of estrogen and progesterone receptors and HER2 is critical when diagnosing invasive breast cancer for optimal treatment. The current evaluation method is via immunohistochemistry (IHC). In this paper, we compared re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c77376ba309081c192d1093fe53613c
http://europepmc.org/articles/PMC6020516
http://europepmc.org/articles/PMC6020516